5076 Participants Needed

Skill-Building Approach for Opioid Abuse

(ISLA Trial)

Recruiting at 2 trial locations
SC
RN
Overseen ByRhonda N Nese, PhD
Age: < 18
Sex: Any
Trial Phase: Academic
Sponsor: University of Oregon
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

This project will test the effectiveness of the Inclusive Skill-building Learning Approach (ISLA) in reducing the use of exclusionary discipline, improving teacher practice and student outcomes, and decreasing substance misuse using a randomized controlled trial in 60 middle schools across six states.

Will I have to stop taking my current medications?

The trial information does not specify whether participants need to stop taking their current medications.

What data supports the effectiveness of the treatment Instructional Skill-Building Learning Approach (ISLA) for opioid abuse?

The IOTOD conference, an educational initiative, has shown that healthcare professionals are increasingly positive about incorporating individualized treatment plans and psychosocial interventions for opioid dependence, suggesting that educational approaches like ISLA may be effective in changing attitudes and practices in opioid abuse treatment.12345

How is the ISLA treatment different from other treatments for opioid abuse?

The ISLA treatment is unique because it focuses on building skills through an instructional approach, which may involve learning and practicing new behaviors to manage opioid abuse, rather than just providing medication or education about overdose prevention.678910

Eligibility Criteria

This trial is for educators (administrators, teachers, instructional assistants, school counselors) in middle schools who have regular contact with students. Participants will be from 60 different schools across six states and must consent to provide data through annual surveys at three time points over two years.

Inclusion Criteria

I am an educator involved with students and will participate in all ISLA activities.
I work at a school participating in a specific study.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Baseline Data Collection

Baseline data collection occurs before the implementation of ISLA

1 year

Treatment

Implementation of ISLA in schools, with training and support for school staff

2 years
Ongoing school visits and support

Follow-up

Participants are monitored for effectiveness of ISLA on student outcomes and substance misuse

1 year

Treatment Details

Interventions

  • Instructional Skill-Building Learning Approach (ISLA)
Trial Overview The Inclusive Skill-building Learning Approach (ISLA) is being tested for its effectiveness in reducing exclusionary discipline practices in schools, improving teacher-student interactions, enhancing student outcomes, and decreasing substance misuse among students.
Participant Groups
4Treatment groups
Experimental Treatment
Active Control
Group I: Wave 2 Instructional Skill-Building Learning Approach (ISLA)Experimental Treatment1 Intervention
Delayed one year after wave 1: Following a baseline year for data collection, school staff in 15 schools will be trained and supported in implementing ISLA schoolwide for two consecutive years.
Group II: Wave 1 Instructional Skill-Building Learning Approach (ISLA)Experimental Treatment1 Intervention
Following a baseline year for data collection, school staff in 15 schools will be trained and supported in implementing ISLA schoolwide for two consecutive years.
Group III: Wave 1 Waitlist ControlActive Control1 Intervention
These 15 schools will receive no intervention while wave 1 intervention schools undergo training and coaching on ISLA.
Group IV: Wave 2 Waitlist ControlActive Control1 Intervention
These 15 schools will receive no intervention while wave 2 intervention schools undergo training and coaching on ISLA.

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Oregon

Lead Sponsor

Trials
91
Recruited
46,700+

National Institute on Drug Abuse (NIDA)

Collaborator

Trials
2,658
Recruited
3,409,000+

Findings from Research

A study involving 24,428 prescribers assessed the impact of extended-release/long-acting opioid training on prescribing behaviors over a 5-year period, but found no significant changes in the proportion of opioid-nontolerant patients receiving ER/LA opioids.
Although there were slight reductions in the concomitant use of central nervous system depressants like benzodiazepines and hypnotics, these changes were not clinically significant, indicating that the training did not lead to meaningful improvements in prescribing practices.
Impact of the extended-release/long-acting opioid analgesics risk evaluation and mitigation strategy on prescribing practices.Secrest, MH., Phillips, S., Cepeda, MS., et al.[2023]
The IOTOD conference has effectively influenced healthcare professionals' attitudes towards managing opioid dependence, with a growing consensus on the importance of individualized treatment plans and psychosocial interventions.
Delegates' commitments to change, measured after educational sessions, indicate that the conference is successfully promoting best practices and improving clinical applications in opioid dependence treatment.
Improving outcomes in the treatment of opioid dependence (IOTOD): reflections on the impact of a medical education initiative on healthcare professionals' attitudes and clinical practice.Webster, S., Robinson, S., Ali, R., et al.[2020]
A technology-assisted education program effectively taught 40 adults at high risk of opioid overdose about opioids and related medications, with significant improvements in test accuracy after each course (p < .001).
Participants completed the program in a median time of 91 minutes, and the learning outcomes were consistent across different backgrounds, indicating the program's broad applicability and potential for reducing overdose risk.
Technology-assisted opioid education for out-of-treatment adults with opioid use disorder.Toegel, F., Novak, MD., Rodewald, AM., et al.[2023]

References

Impact of the extended-release/long-acting opioid analgesics risk evaluation and mitigation strategy on prescribing practices. [2023]
Improving outcomes in the treatment of opioid dependence (IOTOD): reflections on the impact of a medical education initiative on healthcare professionals' attitudes and clinical practice. [2020]
Technology-assisted opioid education for out-of-treatment adults with opioid use disorder. [2023]
Implementing and Evaluating a Multihospital Standardized Opioid Curriculum for Surgical Providers. [2022]
App-Based Pain Management and Opioid Education Program for Patients in Clinic Waiting Rooms. [2021]
Impact of the take ACTION Train-the-Trainer model of opioid overdose education with naloxone distribution- who benefits? [2021]
Randomized controlled trial of a computerized opioid overdose education intervention. [2022]
Evaluation of a simulation-based learning activity for communicating about at-risk opioid behaviors in a community pharmacy setting. [2023]
Exploring the impact of brief training on student pharmacists' naloxone communication skills. [2023]
10.United Statespubmed.ncbi.nlm.nih.gov
Engagement in the Overdose RIsk InfOrmatioN (ORION) e-Health Tool for Opioid Overdose Prevention and Self-Efficacy: A Preliminary Study. [2022]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of ServiceยทPrivacy PolicyยทCookiesยทSecurity